Overcoming Difficult Recruitment Challenges to Meet Vaccine Study Enrollment Goals
Overcoming Difficult Recruitment Challenges to Meet Vaccine Study Enrollment Goals
3 PagesCASE STUDY Overcoming Difficult Recruitment Challenges to Meet Vaccine Study Enrollment GoalsOvercoming Difficult Recruitment Challenges to Meet Vaccine Study Enrollment Goals Patient Population 15,000 adult subjects— aged 50 years or older— at risk for CDI Treatment Period The vaccine or placebo was administered in a 3-dose schedule on days 0, 7, and 30 Drug Class Antibody Study Phase III Business Segment Strategic Solutions (Embedded TM ) Vaccine Solution Regions North America Latin America Western Europe Central Europe Eastern Europe Asia Pacific STUDY DESCRIPTION A randomized, observer-blind, placebo-controlled, multi-center, multi-national, Phase III trial evaluating the efficacy, immunogenicity, and safety of a clostridium difficile (C difficile) tox
